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BACKGROUND: The interaction between prostate cancer cells and osteoblasts is critical for the development of bone metastasis.
Metastatic cancer cells may physically contact osteoblasts in the bone microenvironment; however, the biological significance of this
interaction is not fully understood.
METHODS: Human prostate cancer cells (the osteolytic cell line PC-3 and the osteoblastic cell line MDA-PCa 2b) and human
osteoblasts (hFOB1.19) were cocultured under two different conditions (bilayer and contact conditions). Differential gene expression
profiles of prostate cancer cells were then investigated using microarray analysis. Differentially expressed genes were analysed using
RT–PCR and western blotting, and the effect of anti-cadherin neutralising antibodies on their expression was assayed. The
osteoclastogenic activity of cells grown under these different conditions was also investigated using an in vitro assay.
RESULTS: When PC-3 or MDA-PCa 2b cells were cocultured with hFOB1.19 cells under contact conditions, the expression of eight
genes was upregulated and that of one gene was downregulated in PC-3 cells compared with gene expression in bilayer culture. No
differentially expressed genes were detected in MDA-PCa 2b cells. Four of the eight upregulated genes (interleukin-1b (IL-1b),
cyclooxygenase-2 (COX-2), IL-6 and the third component of complement (C3)) have already been reported to participate in
osteoclastogenesis. Indeed, a cell lysate of PC-3 cells grown under contact coculture conditions significantly enhanced
osteoclastogenesis in vitro (Po0.005). neutralisation of cadherin-11 with a specific antibody inhibited upregulation of COX-2 and
C3 mRNA in PC-3 cells. In contrast, neutralisation of N-cadherin induced upregulation of COX-2 mRNA.
CONCLUSION: Physical contact between osteolytic prostate cancer cells and osteoblasts may upregulate osteoclastogenesis-related
gene expression in prostate cancer cells and enhance osteoclastogenesis. Additionally, cadherin-11 and N-cadherin are involved in
this process. These data provide evidence supporting new therapies of prostate cancer bone metastasis that target direct cancer-cell-
osteoblast cell–cell contact.
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Prostate cancer continues to be the most common cancer, and the
second leading cause of cancer deaths, among American men.
Despite earlier diagnosis and refinements in surgery and radiation,
it was estimated that 28660 men would die from prostate cancer in
the United States in 2008 (Jemal et al, 2008). Moreover, there has
been a recent trend towards an increased incidence of prostate
cancer in Asia, although the rate of prostate cancer in Asia is still
much lower than that in the United States or in many European
countries (Sim and Cheng, 2005). Bone metastasis of prostate
cancer is the major cause of morbidity and mortality, and was
detected at autopsy in up to 90% of patients who died from
prostate cancer (Bubendorf et al, 2000). Metastasis of prostate
cancer cells to bone is a multistep process including detachment of
cancer cells from the primary site, travel of the cells in the blood or
lymph, attachment to bone tissue and development of a tumour at
the site of the bone metastasis. Prostate cancer metastases cause an
osteoblastic (excessive bone forming), osteolytic (bone lysing) or
mixed bone response (Charhon et al, 1983; Cheville et al, 2002;
Roudier et al, 2003).
The interaction between prostate cancer cells and normal cells in
a bone microenvironment is important for survival and prolifera-
tion of metastatic cancer cells. It has been shown that factors
secreted by prostate cancer cells alter bone homoeostasis by
disrupting a balance between osteoblastic and osteoclastic activity
(Roudier et al, 2003; Logothetis and Lin, 2005; Morrissey et al,
2010). In turn, osteoblasts and osteoclasts secrete factors that
facilitate progression of prostate cancer in bone (Lang et al, 1995;
Yin et al, 2005). Once prostate cancer cells have metastasised to
bone marrow, the cancer cells are suspected to interact with
osteoblasts, osteoclasts and stromal cells thorough both soluble
factors and physical contact. Interaction mediated by soluble
factors has been studied using in vitro coculture systems. In those
studies, the conditioned medium of cancer cells, or bilayer
condition using a cell culture insert, was used for coculture
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Fizazi et al, 2003). However, there have been few studies of
the mechanism by which prostate cancer cells physically contact
normal cells in a bone microenvironment. Wang et al (2006)
established a novel physical contact coculture system and showed
that physical contact between prostate cancer cells and bone
marrow stromal cells may act as an independent factor affecting
the progression of bone metastasis. However, interaction between
prostate cancer cells and other normal cells in the bone
microenvironment remains unclear.
A variety of factors, such as morphogenetic proteins, adhesion
molecules, chemotactic factors, cytokines and growth factors, are
known to be involved in the metastasis of prostate cancer to bone
(Mundy, 2002; Roodman, 2004). Adhesion molecules, in particular,
may have a crucial role in the interaction between prostate cancer
cells and normal cells in the bone microenvironment. N-cadherin
and cadherin-11 are highly expressed in prostate cancer cells and
osteoblasts, but not in normal prostate tissue. Cadherin-11
promotes bone metastasis in a mouse model and its expression
increases as the tumour progresses from primary prostate cancer
to metastatic disease in lymph nodes and especially in bone
(Gravdal et al, 2007; Chu et al, 2008). Therefore, heterotypic
interactions between cancer cells and osteoblasts mediated
through homophilic adhesion molecules may have a role in bone
metastasis formation and progression, although the underlying
mechanisms are not fully understood. It is absolutely crucial to
precisely understand these molecular mechanisms in order to
develop new therapies for bone metastasis.
In this study, we compared gene expression of prostate cancer
cells that produce either osteoblastic or osteolytic lesions, after
coculture with osteoblasts using two different coculture systems.
Our study reveals that physical contact between osteolytic prostate
cancer cells and osteoblasts may upregulate the expression of
specific osteoclastogenesis-related genes in prostate cancer cells
and enhance osteoclastogenesis. Additionally, at least in part, this
process is cadherin-11 dependent.
MATERIALS AND METHODS
Histological analysis of bone metastasis in autopsy cases
A total of 229 autopsy cases were reviewed and 37 various cancer
cases with bone metastasis (including two of prostate cancer) were
selected for further analysis. Autopsies had been performed at
Tokushima University Hospital between 2003 and 2008.
Cells and animals
The PC-3 human prostate cancer cell line was obtained from the
Health Science Research Resources Bank (Osaka, Japan). The
MDA-PCa 2b human prostate cancer cell line and hFOB1.19
immortalised human osteoblastic cell line were from the American
Type Cell Culture Collection (Manassas, VA, USA). Both the PC-3
and the MDA-PCa 2b cell line were established from bone
metastases, but the in vivo growth pattern of PC-3 cells is
osteolytic (Uehara et al, 2003), whereas that of MDA-PCa 2b cells is
osteoblastic (Fizazi et al, 2003). The hFOB1.19 cells were
transfected with a gene coding for a temperature-sensitive mutant
(tsA58) of the SV40 large T antigen and exhibit rapid growth at
33.51C (Harris et al, 1995). Before coculture studies, we confirmed
the mRNA expression of alkaline phosphatase and osteocalcin,
markers of osteoblastic differentiation, in hFOB1.19 cells at 371C
using RT–PCR (data not shown). The PC-3 cell line was
maintained in MEM supplemented with 10% fetal bovine serum
(FBS), MDA-PCa 2b was maintained in BRFF-HPC1 (Athena
Environmental Sciences, Baltimore, MD, USA) with 20% FBS
and hFOB1.19 was maintained in phenol red-free DMEM/F12
supplemented with 10% FBS. Penicillin G (100Uml
 1) and
streptomycin sulphate (0.1mgml
 1) were added to all conditioned
media. Male BALB/c mice (6–10 weeks old) and BALB/c nude mice
(5 weeks old) were purchased from Crea Japan (Tokyo, Japan).
Mice were housed and maintained under specific pathogen-free
conditions. Experiments were performed according to the Guide-
line for the Care and Use of Laboratory Animals of the University
of Tokushima School of Medicine, and were approved by the
Animal Care and Use Committee.
Xenograft model of osteolytic bone metastasis
PC-3 cells (5 10
5 per mice) were injected into the proximal tibiae
of nude mice under anaesthesia that consisted of a mixture of
ketamine hydrochloride and xylazine. After 5–9 weeks, the mice
were killed and the hind limbs were excised at the knee joint, fixed
in 10% phosphate-buffered formaldehyde at room temperature for
24h, and then decalcified with 10% EDTA (pH 7.4) at 41C for 2 weeks.
The tissues were then embedded in paraffin, sectioned and subjected
to H&E staining and immunohistochemical staining.
Coculture assay and fluorescence-activated cell sorting
Prostate cancer cells and hFOB1.19 cells were cocultured in contact
and bilayer cocultures. Before coculture, the prostate cancer cells
(PC-3 and MDA-PCa 2b cells) and hFOB1.19 cells were treated
with 10mgml
 1 of the fluorescent dye DiOC18(3) or DiIC18(3)
(Invitrogen, Carlsbad, CA, USA) for 48h. In the contact coculture,
the prostate cancer cells were mixed and cocultured with hFOB1.19
cells in serum- and phenol red-free DMEM/F12 for 48h. The initial
ratio of the cell numbers was set at 1:1. In the bilayer coculture,
the prostate cancer cells were first seeded onto a 6-well plate
(4 10
5 cells per well) and a cell culture insert (PET membrane,
0.4mm pore size, Falcon, Franklin Lakes, NJ, USA) was subse-
quently placed on the top of each well. Equal numbers of hFOB1.19
cells were seeded onto this insert and the plate was cultured for
48h. The medium used for this bilayer coculture was the same as
that used for the contact coculture. In both types of coculture, the
cells were harvested using 1mM EDTA. Prostate cancer cells were
isolated from the cocultured cell mixture using fluorescence-
activated cell sorting (FACS) and the EPICS XL-MCL (Beckman
Coulter, Fullerton, CA, USA). The osteoblast fraction was
simultaneously isolated.
Immunocytochemical staining
After contact coculture, some of the isolated prostate cancer cells
and osteoblasts were reseeded onto MAS-coated slide glass
(Matsunami Glass Ind., Osaka, Japan) and were incubated at
371C for 24h. These cells were fixed in 95% ethanol at room
temperature for 20min, and were then heated in 0.01M citrate
buffer (pH 6.0) for 10min in a pressure cooker for antigen
retrieval. Immunocytochemical staining was performed using the
ChemMate ENVISION kit/horseradish peroxidase (DakoCytoma-
tion, Carpenteria, CA, USA). A monoclonal SV40 T antigen
antibody (PAb416; Calbiochem, Darmstadt, Germany), that reacts
specifically with the SV40 large T antigen but not with SV40 small
T antigen, was added to the slides at a dilution of 1:100, and was
incubated for 1h at room temperature. After washing with PBS,
each slide was treated with horseradish peroxidase-conjugated
secondary antibody for 40min. The signal was visualized using 3,
30-diaminobenzidine, and the cells were then counterstained with
hematoxylin.
Microarray analysis
Total RNA from hFOB1.19, PC-3 and MDA-PCa 2b cells was
isolated using an RNeasy Mini kit (QIAGEN, Valencia, CA, USA).
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Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). RNA
expression was analysed using a GeneChip Human Gene 1.0 ST
Array (Affymetrix, Santa Clara, CA, USA). This microarray chip
contains 28869 oligonucleotide probes for known and unknown
genes. First strand cDNA was synthesised from 300ng of total RNA
using GeneChip whole transcript (WT) cDNA Synthesis and
Amplification kit (Affymetrix) according to the manufacturer’s
protocol. Complementary RNA (10mg) was input into the second-
cycle cDNA reaction and then this cDNA was fragmented and end-
labeled with the GeneChip WT Terminal Labelling kit (Affyme-
trix). Approximately 5.5mg of labelled DNA target was hybridised
to the Affymetrix GeneChip Human Gene 1.0 ST Array at 451C for
17h on a GeneChip Hybridisation 640 (Affymetrix) according to
the manufacturer’s recommendation. Hybridized arrays were
washed and stained on a GeneChip Fluidics Station 450, were
scanned using a GeneChip Scanner 3000 7G (Affymetrix) and then
CEL files were generated for each array. This analysis was
supported by the Support Center for Advanced Medical Sciences,
the University of Tokushima Graduate School, Institute of Health
Biosciences.
Semiquantitative RT–PCR
RNA molecules identified in the microarray analysis were
subjected to semiquantitative RT–PCR analysis. Aliquots (2mg
per reaction) were reverse-transcribed using SuperScript II reverse
transcriptase and random hexamers (Invitrogen). This reaction
was conducted at 421C for 60min, after which the temperature was
increased to 721C for 15min. The total cDNA was then amplified
using PCR by following a thermocycling program of 941C for
10min for initial denaturation, 28 cycles of 941C for 30s, 551C for
1min, 721C for 1min for amplification, and a final extension at
721C for 10min. The sequences of these primers are listed in
Table 1. The RT–PCR products were separated by 1.5% agarose gel
electrophoresis and were visualized using an UV transilluminator.
ELISA and western blot analysis
After sorting, cocultured PC-3 cells were resuspended in phosphate-
buffered saline containing 1mM phenylmethylsulfonyl fluoride
and were lysed using an ultrasonic homogenizer. These homo-
genates were then centrifuged and the supernatants were used
as protein samples. The protein concentrations of the samples
were quantified using the DC Protein Assay kit (Bio-Rad, Hercules,
CA, USA). Aliquots (8mg protein) were subjected to ELISA assays
for IL-1b (Human IL-1b ELISA kit, Invitrogen), IL-6 (Quantikine
human IL-6 immunoassay kit, R&D Systems, Minneapolis, MN,
USA) and C3 (AssayMax human complement C3 ELISA kit,
Assaypro, St Charles, MO, USA). Aliquots (10mg protein) were also
subjected to western blot analysis as described previously
(Takahashi et al, 2008). Rabbit anti-COX-2 (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) and anti-actin (Sigma, St Louis, MO,
USA) antibodies were used as the primary antibodies. Goat anti-
rabbit IgG-horseradish peroxidase (Invitrogen) was employed as
the secondary antibody. The dilutions used are as follows: anti-
COX-2, 1:250; anti-actin, 1:10000; and anti-rabbit IgG-horse-
radish peroxidase, 1:200000. An immobilon western horseradish
peroxidase substrate (Millipore, Billerica, MA, USA) was used to
detect the signals.
Immunohistochemical staining
Paraffin sections (4mm) of bone lesions from a xenograft model of
osteolytic bone metastasis were deparaffinized in xylene and
dehydrated through descending concentrations of ethanol. Antigen
retrieval and immunostaining was performed according to the
immunocytochemical staining protocol described above. A mono-
clonal mouse anti-COX-2 antibody (COX 229; Invitrogen) was
used as the primary antibody at dilution of 1:50.
In vitro osteoclastogenesis assay
Bone marrow was collected from male BALB/c mice by flushing
the femurs and tibias with serum-free DMEM. The cells were then
washed twice in the same medium, were seeded onto a 100mm
dish and were cultured in 10% FBS-containing DMEM at 371C for
1 week. During culture, the medium was changed every three days.
Adherent cells were reseeded onto a 96-well microplate (1 10
4
cells per well), were preincubated at 371C for 24h and were then
treated with each cell lysate from PC-3 cells cocultured with hFOB
1.19 cells under contact or bilayer conditions (10mg) in the
presence of receptor activator for nuclear factor-kB ligand
(RANKL, R & D systems, Mineapolis, MN, USA) and macrophage
colony-stimulating factor (M-CSF) (10ngml
 1; R&D Systems)
after changing to flesh complete medium. After incubation for 10
days, the cells were fixed in 5% phosphate-buffered formaldehyde
at room temperature for 5min and tartrate-resistant acid
phosphatase (TRAP) staining was conducted to detect differen-
tiated osteoclasts. The composition of the TRAP staining solution
was described in our previous report (Takahashi et al, 2008). The
number of TRAP-positive cells in more then five microscopic
fields was counted at  200 magnification.
Neutralisation assay
PC-3 and hFOB1.19 cells were treated with DiOC18(3) and
DiIC18(3), respectively. The conditions of treatment were the same
as described above. Before contact coculture, the hFOB1.19 cells
were treated with 40mgml
 1 of neutralising anti-N-cadherin
(Sigma) or anti-Cadherin-11 (R&D Systems) antibody, or of the
corresponding isotype IgG for 30min at 371C. These antibody-
treated hFOB1.19 cells and PC-3 cells were mixed and cocultured
in serum- and phenol red-free DMEM/F12 for 48h. The initial ratio
of cell numbers was set at 1:1. PC-3 cells were isolated using FACS
sorting as described above. Isolated PC-3 cells were used for
semiquantitative RT–PCR analyses for COX-2, IL-1b, IL-6 and C3
mRNA. Calculations of signal intensities were performed by using
NIHimage 1.62 software (http://rsbweb.nih.gov/nih-image/).
Table 1 Primers for RT–PCR
Marker Forward (50–30) Reverse (50–30) Size (bp) Reference
COX-2 CGCAGTACAGAAAGTATC CTCTGGATCTGGAACAC 433 Takahashi et al, 2008
IL-1b GAGCTCGCCAGTGAAATG TGCATCGTGCACATAAGC 336 Takahashi et al, 2008
IL-6 AATTCGGTACATCCTCGAC TTCTGTGCCTGCAGCTTC 381 Takahashi et al, 2008
C3 CAGGCAGCATCACTAAAG CCTTGGTCTCTTCTGATC 480 Original
N-cadherin GACAACATTCACTGCTCA GAACTTCATAGATACCAG 488 Original
Cadherin-11 CAAGTTACATCCACGAAG ATCTCGGTTGTCTCTGAC 488 Original
b-actin TACAATGAGCTGCGTGTGG AGATGGGCACAGTGTGGG 226 Takahashi et al, 2008
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A two-tailed Student’s t-test was employed for statistical analyses
of the data. Significant results were determined at a Po0.05.
RESULTS
Histological findings of direct cancer-cell-osteoblast
contact in bone metastasis
We first determined if cancer-cell-osteoblast cell–cell contact
could be observed in bone lesions in a xenograft model of
osteolytic bone metastasis. Bone surfaces facing tumours were
extensively lysed by osteoclasts. However, in some areas, residual
osteoblasts were observed very close to cancer cells suggesting
direct cancer-cell-osteoblast contact (Figure 1A and B).
We next determined how often direct cancer-cell-osteoblast
contact occurs in human tumours, by reviewing H&E-stained
slides of 37 autopsy cases with bone metastases. The primary
tumour sites of these cases were as follows: lung (17 cases), large
intestine (4 cases), gallbladder (3 cases), pancreas, bladder and
prostate (2 cases each), pleura, breast, stomach, liver, bile duct,
kidney and soft tissue (1 case each). The bone metastases in the
two case of prostate cancer were osteoblastic, and those in the
other cases were osteolytic. The close proximity of cancer cells to
osteoblasts suggesting direct cancer-cell-osteoblast contact was
also observed to varying extents in all cases (Figure 1C and D).
Immunocytochemical staining of the SV 40 large T antigen
To further analyze cancer-cell-osteoblast contact, the human
prostate cancer cells (PC-3 and MDA-PCa 2b calls) and hFOB1.19
osteoblasts, which were labelled with 10mgml
 1 of the fluorescent
dye DiOC18(3) and DiIC18(3), respectively, were cocultured in
contact or in bilayer cocultures for 48h. Following coculture in
contact cocultures, the prostate cancer cells and osteoblasts were
then separated by sorting for further analyses. To confirm the
purity of separated cell populations (DiOC18(3)-labeled human
prostate cancer cells and DiIC18(3)-labeled human osteoblasts)
after sorting, the cells were immunocytochemically stained for the
SV40 large T antigen, which is a marker of hFOB1.19 cells. As
shown in Figure 2, the nuclei of hFOB1.19 cells (DiOC18(3)
 /
DiIC18(3)
þ) stained positive for the SV40 large T antigen, whereas
no positive staining of PC-3 or MDA-PCa 2b cells (DiOC18(3)
þ/
DiIC18(3)
 ) was observed (MDA-PCa 2b cells are not shown in
Figure 2). Thus, prostate cancer cells and osteoblasts can be
completely separated by sorting after coculture in contact
cocultures.
Gene expression analysis
We next performed cDNA microarray analysis of prostate cancer
cells that had been cocultured with osteoblasts, to identify
differential gene expression in prostate cancer cells because of
physical contact with the osteoblasts. We compared gene
expression in cocultures of both osteoblastic (MDA-PCa 2b) and
osteolytic (PC-3) prostate cancer cell lines with osteoblasts under
bilayer and contact culture conditions. As controls, the prostate
cancer cells were cultured alone in the absence of osteoblasts.
Under bilayer coculture conditions, there is no physical contact
between the prostate cancer cells and the osteoblasts, but each cell
line is exposed to soluble factors secreted by both cell types. In
contrast, under contact coculture conditions, cancer cells and
osteoblasts are both physically in contact and are exposed to
soluble factors secreted by both cell types. The control prostate
cancer cells cultured alone have no interaction with osteoblasts.
The microarray results of the prostate cancer cells cultured alone
were compared with those of prostate cancer cells from the bilayer
Bo
Bo
PC
PC
Bo Bo
Bo
PC
PC
PC
PC
Figure 1 Histological findings suggesting direct prostate cancer-cell-osteoblast contact in bone metastases. The indicated tissues were fixed and analysed
following H&E staining. (A and B) An osteolytic lesion produced by the growth of PC-3 human prostate cancer cells in the tibia of a nude mouse. The close
proximity of PC-3 cells to osteoblasts suggesting direct cancer-cell-osteoblast contact, as well as osteolysis by osteoclasts was observed. (C and D)
Representative osteoblastic bone metastases of autopsy cases of prostate cancer. The close proximity of prostate cancer cells to osteoblasts suggesting
direct cancer-cell-osteoblast contact was also observed. Arrows, osteoblasts; arrow heads, osteoclasts; Bo, bone; PC, prostate cancer cells. Scale ¼50mm.
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coculture were further compared with those of cells from the
contact coculture. A fold change in gene expression that was 43.0
or o0.33 was considered significant. There was no significant
difference in gene expression between PC-3 cells cultured alone
and those cocultured under bilayer conditions. This result
suggested that soluble factors presents in the coculture did not
affect the gene expression in PC-3 cells. In contrast, when the gene
expression of PC-3 cells cultured under contact coculture
conditions was compared with that of PC-3 cells cultured under
bilayer coculture conditions, eight upregulated genes (3.2–5.3-
fold) and one downregulated gene (0.3-fold) were identified in the
contact cocultures (Table 2). Thus, the expression of these genes
appeared to be specifically regulated by direct contact between
PC-3 cells and osteoblasts. We then determined if these regulated
genes might be related to genes that are known to be involved in
cancer metastasis and bone remodelling. Four of the eight
upregulated genes (IL-1b, COX-2, IL-6 and C3) have already
been reported to participate in osteoclastogenesis (Mangham et al,
1993; Sato et al, 1993; Garcı ´a-Moreno et al, 2002; Roodman, 2004;
Liu et al, 2005; Singh et al, 2007; Bussard et al, 2008). There was no
significant difference in the gene expression of MDA-PCa 2b cells
under any culture conditions.
Validation of cDNA microarray results
To confirm the microarray results, the mRNA expression of the
four osteoclastogenesis-related genes that were upregulated in
PC-3 cells following coculture with hFOB1. A total of 19 cells under
contact conditions were examined using RT–PCR. Consistent with
the cDNA microarray results, upregulation of IL-1b, COX-2, IL-6
and C3 mRNA were detected in PC-3 cells under contact coculture
conditions compared with under bilayer coculture conditions
(Figure 3A).
We next determined the expression of IL-1b, COX-2, IL-6 and
C3 in PC-3 cells at the protein level. The protein levels of IL-1b,
IL-6 and C3 were measured using ELISA. A PC-3 cell lysate was
used for ELISA, rather than culture supernatant, to eliminate the
influence of exogenous IL-1b, IL-6 and C3 secreted by osteoblasts
in the coculture. The level of IL-6 in PC-3 cells was significantly
higher (Po0.001) under contact coculture conditions than in PC-3
cells under bilayer coculture conditions, whereas the level of IL-1b
was not significantly different between the two coculture condi-
tions (Figure 3B). The level of C3 in PC-3 cells was below the limits
of detection under both bilayer and contact coculture conditions.
Expression of COX-2 was determined by western blotting. The
expression level of COX-2 was higher in PC-3 cells under contact
coculture conditions than under bilayer coculture conditions
(Figure 3C). Expression of COX-2 in the osteolytic bone metastasis
model was also examined using immunohistochemistry. PC-3 cells
formed solid tumour within the bone microenvironment in this
tumour model, and strongly expressed COX-2 at the periphery of
the tumour adjacent to the bone (Figure 3D, left). The close proximity
of PC-3 cells to osteoblasts suggesting direct cancer-cell-osteoblast
hFOB 1.19 PC-3
Figure 2 Immunohistochemical analysis of the SV40 large T antigen after sorting of cells in contact cocultures. PC-3 human prostate cancer cells (labelled
with DiOC18(3)) were mixed and cocultured with DiIC18(3)-labeled human osteoblasts expressing SV40 (hFOB1.19) for 48h. Cocultured prostate cancer
cells (DiOC18(3)
þ/DiIC18(3)
 ) and hFOB1.19 cells (DiOC18(3)
 /DiIC18(3)
þ) were then separated using flow cytometry. One thousand cells from each
sorted cell population were cultured overnight on glass slides and were then immunohistochemically stained for the SV40 large T antigen. Positive staining
of the SV40 large T antigen was observed in the nuclei of hFOB1.19 cells (DiOC18(3)
 /DiIC18(3)
þ) but not in PC-3 cells (DiOC18(3)
þ/DiIC18(3)
 ).
Scale ¼100mm.
Table 2 Up-/downregulated genes in PC-3 cells cultured under contact
coculture conditions, identified by cDNA microarray analysis
Gene bank
accession no. Gene name
Fold
change
a
Upregulated genes in contact coculture conditions
NM_007115 Tumor necrosis factor, alpha-induced protein 6 5.3
NM_000576 Interleukin 1-b 4.4
NM_000963 Prostaglandin-endoperoxide synthase 2 (COX2) 4.2
NM_001442 Fatty acid binding protein 4, adipocyte 4.0
NM_000600 Interleukin 6 (interferon, b-2) 3.7
NM_007028 Tripartite motif-containing 31 3.5
NR_003006 Small Cajal body-specific RNA 6 on chromosome 2 3.4
NM_000064 Complement component 3 3.2
Downregulated genes in contact coculture conditions
NM_003118 Secreted protein, acidic, cysteine-rich (osteonectin) 0.3
aThe microarray results of PC-3 cells in the contact coculture were compared with
those of cells from the bilayer coculture. The fold change in gene expression that was
43.0 or o0.33 was considered significant.
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areas that were distant from the bone, COX-2 expression was
very low (Figure 3D, right). These results suggest that COX-2
expression in osteolytic prostate cancer cells correlates with
physical contact between the cancer cells and osteoblasts in the
bone microenvironment.
In vitro osteoclastogenesis
To examine the effect of physical contact between osteolytic cancer
cells and osteoblasts on osteoclastogenic activity of cancer cells, an
in vitro osteoclastogenesis assay was performed. In this assay, PC-3
cells that had been grown under contact or bilayer coculture
conditions were lysed, and this lysate was then incubated with
adherent bone marrow cells in the presence of RANKL and M-CSF
for 10 days. The cells were then fixed and differentiated osteoclasts
were detected by microscopic observation of TRAP staining. As
shown in Figure 4, treatment with a cell lysate from PC-3 cells
cocultured with hFOB1.19 cells under bilayer and contact
conditions resulted in 20±3 and 31±7 TRAP-positive cells per
field, respectively. The difference in number between the two
culture conditions was statistically significant (Po0.005). These
results suggest that the osteoclastogenic activity of osteolytic
prostate cancer cells is enhanced by physical contact with
osteoblasts.
N-cadherin and cadherin-11 neutralisation assay
We hypothesized that upregulation of osteoclastogenesis-related
genes in PC-3 cells in contact cocultures may be induced by
adhesion molecules that mediate interactions between PC-3
and hFOB1.19 cells. Both N-cadherin and cadherin-11 are
overexpressed in osteoblasts (Marie, 2002; Mbalaviele et al, 2006)
and prostate cancer cells (Tomita et al, 2000; Chu et al, 2008) and
are considered to have an important role in bone metastasis of
prostate cancer. We therefore determined if these cadherins might
have a role in the upregulation of osteoclastogenesis-related genes
in PC-3 cells under contact coculture conditions. For this purpose,
we assayed if neutralisation of these cadherins using specific
N-cadherin and cadherin-11 neutralising antibodies might inhibit
the observed upregulation of these genes in PC-3 cells. We first
confirmed that N-cadherin and cadherin-11 are expressed in both
hFOB1.19 and PC-3 cells using RT–PCR (Figure 5A). Following
pretreatment of hFOB1.19 cells with the cadherin-11 neutralising
antibody, the upregulation of COX-2 and C3 mRNA that occurs in
PC-3 cells under contact coculture conditions was inhibited. The
ratio in level of COX-2 and C3 in anti-cadherin-11 antibody-
treated cells to that in control antibody-treated cells were 0.49 and
0.60, respectively. In contrast, the upregulation of IL-1b and IL-6
mRNAs was not. Inversely, pretreatment with the N-cadherin-
neutralising antibody further increased the upregulation of COX-2
mRNA. The ratio in level of COX-2 in anti-N-cadherin antibody-
treated cells to that in control antibody-treated cells was 1.70
(Figure 5B). These results suggest that upregulation of osteoclas-
togenesis-related genes in PC-3 cells under contact coculture
conditions is, at least in part, associated with both N-cadherin and
cadherin-11.
DISCUSSION
In this study, we have shown that physical contact between
osteolytic prostate cancer cells and osteoblasts may upregulate the
expression of osteoclastogenesis-related genes in prostate cancer
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Figure 3 Analysis of IL-1b, COX-2, IL-6 and C3 expression in PC3 cells cocultured with hFOB1.19 cells. (A) The mRNA expression of the four
osteoclastogenesis-related genes, IL-1b, COX-2, IL-6 and C3, in PC-3 cells following coculture under contact and bilayer conditions, was analysed using
RT–PCR. Consistent with the cDNA microarray results, these genes were upregulated in contact cocultured PC-3 cells compared with bilayer cocultured
cells. The primers used for RT–PCR are shown in Table 1. (B) Measurement of IL-6 and IL-1b levels in PC-3 cells using ELISA. The level of IL-6 was
significantly higher (Po0.001) in PC-3 cells under contact coculture conditions than under bilayer coculture conditions, whereas IL-1b levels did not
significantly differ between the two coculture conditions. ELISA was performed using a PC-3 cell lysate. (C) Analysis of COX-2 expression in PC-3
cells by western blotting. Expression of COX-2 was higher in PC-3 cells under contact coculture conditions than under bilayer coculture conditions.
(D) Immunohistochemical analysis of COX-2 expression in an osteolytic bone metastasis model. Left: Strong expression of COX-2 in PC-3 cells adjacent
to the bone. The close proximity of PC-3 cells to osteoblasts suggesting direct cancer-cell-osteoblast contact was observed in this area. Right: very low
expression of COX-2 in PC-3 cells distant from the bone. Bo, bone; PC, prostate cancer cells. Scale¼50mm.
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scells, and enhance osteoclastogenesis. Microarray analysis of genes
that were only expressed under contact coculture conditions and
not under bilayer conditions, were considered to be specifically
induced by physical contact between prostate cancer cells and
osteoblasts.
We identified eight upregulated genes and one downregulated
gene in PC-3 cells that were regulated only under contact coculture
conditions. Interaction between cancer cells and osteoblasts has
been previously studied using in vitro coculture systems in which
conditioned medium or cell culture inserts have been employed.
The results of these types of studies only reflect the effects of
soluble factors and not of direct cell–cell contact. In our study, we
did not detect any genes that were differentially expressed because
of coculture of PC-3 cells and osteoblasts under bilayer conditions,
where the PC-3 cells are only exposed to soluble factors produced
by the osteoblasts. These results suggest that the contact coculture
system may be useful for understanding the molecular mechan-
isms of interaction between prostate cancer cells and osteoblasts
and for the detection of new molecular targets for the treatment of
bone metastasis. Wang et al previously analysed gene expression
in a contact coculture of PC-3 cells and rat bone marrow stromal
cells. They detected 18 genes in PC-3 cells and 10 genes in bone
marrow stromal cells, expression of which was regulated only in
the physical contact coculture system (Wang et al, 2006). However,
the regulated genes that they detected did not overlap with the
genes that were regulated in our coculture system, indicating that
osteoblasts and bone marrow stromal cells have different roles in
prostate cancer bone metastasis.
Four of the eight genes that we found to be upregulated in PC-3
cells under contact coculture conditions, that is, IL-1b, COX-2,
IL-6 and C3 have already been reported to participate in osteoclas-
togenesis (Mangham et al, 1993; Sato et al, 1993; Garcı ´a-Moreno
et al, 2002; Roodman, 2004; Liu et al, 2005; Singh et al, 2007;
Bussard et al, 2008).
Cyclooxygenase-2 is an inducible prostaglandin synthesis
enzyme, and is indirectly involved in bone resorption and
osteoclastogenesis through prostaglandin E2 (PGE2) (Akatsu
et al, 1989; Ohshiba et al, 2003). The expression of COX-2 is
upregulated in many cancers. The product of COX-2, prostaglan-
din H2, is converted by PGE2 synthase into PGE2, which can stimu-
late cancer progression (Menter et al, 2010). Cyclooxygenase-2
is overexpressed in primary prostate cancer with metastatic
potential and its expression is associated with death from prostate
carcinoma (Richardsen et al, 2010). Previously we have shown that
neutralisation of PGE2 using a soluble E-prostanoid receptor 2,
inhibits the growth of PC-3 cells and tumour-induced osteoclasto-
genesis in a mouse model of bone metastasis (Takahashi et al, 2008).
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Figure 5 Effect of the blockade of N-cadherin- and cadherin-11-dependent cell adhesion between PC-3 and hFOB1.19 cells. (A) Confirmation of
N-cadherin and cadherin-11 expression in both PC-3 cells and hFOB1.19 cells using RT–PCR. (B) Effects of N-cadherin or cadherin-11 neutralising antibodies
on osteoclastogenesis-related gene expression in PC-3 cells under contact coculture conditions. The hFOB1.19 cells were pretreated with N-cadherin- or
cadherin-11-neutralising antibodies for 30min at 371C, and then contact coculture with PC-3 cells was initiated. After 48h, RNA was extracted from sorted
PC-3 cells and was used as a template for RT–PCR to analyze the expression of the indicated osteoclastogenic genes. Signal intensities of each band were
quantified by using NIHimage 1.62 software and normalised by that of b-actin. Data are representative of two separate experiments. The cadherin-11
neutralising antibody inhibited the upregulation of COX-2 and C3 mRNA, whereas the N-cadherin neutralising antibody further induced the upregulation of
COX-2 mRNA.
Bilayer
co culture
Contact
co culture
N
o
.
 
o
f
 
T
R
A
P
+
 
c
e
l
l
s
0
10
20
30
40
50
P < 0.005
Figure 4 Osteoclastogenic activity of PC-3 cells cocultured with
hFOB1.19 cells. The effect of addition of a cell lysate from PC-3 cells,
grown under contact or bilayer coculture conditions, on osteoclastogenesis
of bone marrow cells in an in vitro osteoclastogenesis assay, was determined
by microscopic analysis of the number of tartrate-resistant acid
phosphatase (TRAP) cells. The number of TRAP-positive cells in more
than five microscopic fields was counted ( 200 magnification). Osteo-
clastogenesis was significantly enhanced by the cell lysate of PC-3 cells
grown under contact coculture conditions compared with osteoclastogen-
esis with a lysate of cells grown under bilayer coculture conditions
(Po0.005). Data are representative of two separate experiments.
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sThus, our microarray results, that COX-2 expression is only
upregulated in osteolytic PC-3 cells and not in osteoblastic
MDA-PCa 2b cells, is consistent with the evidence that COX-2
and PGE2 are key molecules for osteolytic bone metastasis.
Furthermore, immunohistochemical analysis of an osteolytic bone
metastasis model showed that COX-2 is strongly expressed in PC-3
cells that are adjacent to the bone and are locally in contact with
osteoblasts, and is weakly expressed in PC-3 cells that are distant
from the bone. These results suggest that the contact and bilayer
coculture system may mimic the in vivo situation of metastatic
cancer cells adjacent to and distant from the bone, respectively.
Interleukin-6 is a mediator of PGE2-induced suppression of
osteoprotegerin production by osteoblasts and enhances osteoclast
differentiation (Liu et al, 2005). Interleukin-6 and the IL-6 receptor
have been identified in human prostate carcinoma (Siegsmund
et al, 1994) and IL-6 acts as an autocrine and paracrine growth
factor in androgen-refractory prostate cancer cells including PC-3
cells (Chung et al, 1999). Immunohistochemical investigation of
prostate cancer metastases and xenografts showed that IL-6 is
expressed in the majority of prostate cancer bone metastases and
to a lesser extent in prostate cancer soft tissue metastases
(Morrissey et al, 2010). Our data is consistent with the results of
these reports.
IL-1b has been found to increase the formation as well as the
resorptive capacity of osteoclasts in culture (Trebec-Reynolds et al,
2010), and can induce IL-8 production in prostate cancer cells,
which promotes prostate cancer cell proliferation and migration
(Tsai et al, 2009). Although we confirmed the cDNA microarray
result of IL-1b mRNA upregulation using RT–PCR, the protein
level of IL-1b in PC-3 cell lysates was not significantly different
under bilayer and contact coculture conditions. The reason for this
discrepancy is unknown, but it may involve posttranscriptional or
posttranslational regulatory mechanisms.
C3 participates in osteoclast development by potentiating
M-CSF-dependent proliferation of bone marrow cells and induction
of osteoclast differentiation (Sato et al, 1993). The concentrations
of C3 in prostatic fluid are significantly greater in patients with
prostate cancer than those with benign prostate hyperplasia.
However, in our study it was not possible to determine differences
in the level of C3 protein between PC-3 cells under bilayer and
contact coculture conditions, as the C3 protein level was below the
limits of detection of ELISA analysis.
The roles of other four upregulated genes, that is, tumour
necrosis factor, alpha-induced protein 6, fatty acid binding protein 4,
tripartite motif-containing 31, small Cajal body-specific RNA 6
on chromosome 2 and one downregulated gene, that is, secreted
protein acidic and rich in cysteine (SPARC; also known as
osteonectin) on osteoclastogenesis and bone metastasis must be
clarified in future studies. Especially, SPARC has been assumed to
be important in human prostate cancer bone metastasis as a major
bone-derived chemoattractant for prostate cancer cells (Jacob et al,
1999). On the other hand, downregulation of endogenous SPARC
by small interference RNA accelerates prostate cancer cell-line
proliferation and matrix invasiveness (Said et al, 2009). Participa-
tion of SPARC in osteoclastogenesis is unclear. However, SPARC
stimulates the synthesis of osteoprotegerin, a physiological
inhibitor of osteoclastogenesis, in human periodontal ligament
cells (Fujita et al, 2002).
We showed that PC-3 cells that were cocultured with hFOB1.19
cells under contact conditions had significantly higher osteoclasto-
genic activity in an in vitro osteoclastogenesis assay than cells
cultured under bilayer conditions. On the basis of the observed
protein expression levels, it would appear that COX-2 and IL-6, rather
than IL-1b and C3, are the major molecules that influence this
enhancement of osteoclastogenesis in the contact coculture system.
Cell adhesion molecules have been suggested to have a primary
role in the interactions between tumour cells and host environ-
ment (Michigami et al, 2000; Cowin et al, 2005). In particular,
cadherins have been proposed to function as tumour promoter
factors during cancer invasion and organ preferential metastasis
(Pishvaian et al, 1999; Gravdal et al, 2007). N-cadherin and
cadherin-11 are transmembrane calcium-dependent and homo-
philic cell–cell adhesion molecules. These molecules have been
detected in prostate cancers (Tomita et al, 2000) and in osteoblasts
(Cheng et al, 1998; Mbalaviele et al, 2006) and have been reported
to be implicated in cancer invasion and human osteoblast
differentiation (Kii et al, 2004; Chu et al, 2008). These finding
led us to hypothesize that N-cadherin and cadherin-11 may
participate in the upregulation of osteoclastogenesis-related genes
that was mediated by physical contact between PC-3 and hFOB1.19
cells. Consistent with previous studies, we found that N-cadherin
and cadherin-11 were both expressed in PC-3 and hFOB1.19 cells.
Pre-treatment of hFOB1.19 cells with cadherin-11-neutralising
antibody before initiation of the coculture inhibited the upregula-
tion of COX-2 and C3 mRNA that was induced in PC-3 cells under
contact coculture conditions. In contrast, pre-treatment with
N-cadherin neutralising antibody upregulated COX-2 mRNA in
PC-3 cells under contact coculture conditions. These data suggest
that cadherin-11 and N-cadherin are involved in the process of
osteoclastogenesis that is induced by physical contact between
osteolytic prostate cancer cells and osteoblasts.
There is a great deal of evidence indicating that interaction
between prostate cancer cells and osteoblasts has an important role
in the survival and growth of metastatic cancer cells in a bone
microenvironment (Logothetis and Lin, 2005; Morrissey et al,
2010). Physical contact between cancer cells and osteoblasts has
been suggested to be involved in these processes. However, when
we histologically analysed osteolytic tumours that were produced
by intratibial injection of PC-3 cells into nude mice, the bone
surfaces facing the tumours were extensively lysed by osteoclasts.
Although residual osteoblasts and the close proximity of PC-3 cells
to osteoblasts suggesting direct cancer-cell-osteoblast contact was
observed in some areas (Figure 1A), the question remained
whether this type of cell–cell contact is common in human cases of
bone metastases or not. However, in all 37 autopsy cases with
osteoblastic or osteolytic bone metastases that we reviewed, the
close proximity of cancer cells to osteoblasts suggesting direct
cancer-cell-osteoblast contact was observed to varying extents.
Although we could not confirm direct cancer-cell-osteoblast
contact by electron microscopy, these results suggest that direct
cancer-cell-osteoblast contact is common, at least in advanced
bone metastases. In future studies, it must be clarified whether
metastatic cancer cells physically contact with osteoblasts in early
bone metastasis, either as a single cell or as a small focus of cells.
In this study, we have shown that direct metastatic cancer-cell-
osteoblast contact likely to be a common event in cases with
advanced bone metastases. We further show that physical contact
between osteolytic prostate cancer cells and osteoblasts may
enhance the osteoclastogenic activity of prostate cancer cells by
inducing upregulation of the gene expression of specific osteo-
clastogenesis-related genes. Additionally, this process is, at least in
part, cadherin-11 dependent. These data provide evidence to
support the design of new therapies of prostate cancer bone
metastasis that target direct cancer-cell-osteoblast contact.
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